QUESTCOR PHARMACEUTICALS INC Research and Development Expense
QUESTCOR PHARMACEUTICALS INC reported Research and Development Expense of $22.01 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-07-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-07-25
- QUESTCOR PHARMACEUTICALS INC research and development expense for the quarter ending 2014-06-30 was $22.01M, a 79.80% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC research and development expense for the quarter ending 2014-03-31 was $19.93M, a 84.65% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC research and development expense for the quarter ending 2013-12-31 was $19.60M, a 61.71% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC research and development expense for the quarter ending 2013-09-30 was $17.09M, a 113.76% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC research and development expense for fiscal 2013 was $59.73M, a 74.30% increase from fiscal 2012.
- QUESTCOR PHARMACEUTICALS INC research and development expense for fiscal 2012 was $34.27M, a 104.25% increase from fiscal 2011.
- QUESTCOR PHARMACEUTICALS INC research and development expense for fiscal 2011 was $16.78M, a 53.45% increase from fiscal 2010.
- QUESTCOR PHARMACEUTICALS INC research and development expense for fiscal 2010 was $10.93M, a 13.27% increase from fiscal 2009.
| Period end | Research and Development Expense 2 month | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2014-06-30 | $22.01M 10-Q · filed 2014-07-25 | $41.94M 10-Q · filed 2014-07-25 | $61.54M derived: sum of 3 quarters · filed 2014-07-25 | $78.63M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2014-03-31 | $19.93M 10-Q · filed 2014-04-29 | $39.53M derived: sum of 2 quarters · filed 2014-04-29 | $56.63M derived: sum of 3 quarters · filed 2014-04-29 | $68.87M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2013-12-31 | $19.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $36.70M derived: sum of 2 quarters · filed 2014-02-26 | $48.94M derived: sum of 3 quarters · filed 2014-07-25 | $59.73M 10-K · filed 2014-02-26 | |
| 2013-09-30 | $17.09M 10-Q · filed 2013-10-30 | $29.33M derived: sum of 2 quarters · filed 2014-07-25 | $40.13M 10-Q · filed 2013-10-30 | $52.25M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2013-06-30 | $12.24M 10-Q · filed 2014-07-25 | $23.03M 10-Q · filed 2014-07-25 | $35.16M derived: sum of 3 quarters · filed 2014-07-25 | $43.15M derived: sum of 4 quarters · filed 2014-07-25 | |
| 2013-03-31 | $10.79M 10-Q · filed 2014-04-29 | $22.91M derived: sum of 2 quarters · filed 2014-04-29 | $30.91M derived: sum of 3 quarters · filed 2014-04-29 | $39.40M derived: sum of 4 quarters · filed 2014-04-29 | |
| 2012-12-31 | $12.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $20.12M derived: sum of 2 quarters · filed 2014-02-26 | $28.60M derived: sum of 3 quarters · filed 2014-02-26 | $34.27M 10-K · filed 2014-02-26 | |
| 2012-09-30 | $8.00M 10-Q · filed 2013-10-30 | $16.48M derived: sum of 2 quarters · filed 2013-10-30 | $22.15M 10-Q · filed 2013-10-30 | $27.88M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-09-01 | $8.00M 10-Q · filed 2012-10-23 | ||||
| 2012-06-30 | $8.48M 10-Q · filed 2013-07-31 | $14.15M 10-Q · filed 2013-07-31 | $19.88M derived: sum of 3 quarters · filed 2014-02-26 | $24.06M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-03-31 | $5.67M 10-Q · filed 2013-05-02 | $11.39M derived: sum of 2 quarters · filed 2014-02-26 | $15.57M derived: sum of 3 quarters · filed 2014-02-26 | $19.46M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2011-12-31 | $5.73M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-02-26 | $9.91M derived: sum of 2 quarters · filed 2014-02-26 | $13.80M derived: sum of 3 quarters · filed 2014-02-26 | $16.78M 10-K · filed 2014-02-26 | |
| 2011-09-30 | $4.18M 10-Q/A · filed 2012-10-25 | $8.07M derived: sum of 2 quarters · filed 2012-10-25 | $11.05M 10-Q/A · filed 2012-10-25 | $14.11M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-09-01 | $4.18M 10-Q · filed 2012-10-23 | ||||
| 2011-06-30 | $3.89M 10-Q · filed 2012-07-25 | $6.87M 10-Q · filed 2012-07-25 | $9.94M derived: sum of 3 quarters · filed 2013-02-27 | $12.12M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-03-31 | $2.98M 10-Q · filed 2012-04-26 | $6.05M derived: sum of 2 quarters · filed 2013-02-27 | $8.22M derived: sum of 3 quarters · filed 2013-02-27 | $11.17M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2010-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $5.24M derived: sum of 2 quarters · filed 2013-02-27 | $8.19M derived: sum of 3 quarters · filed 2013-02-27 | $10.93M 10-K · filed 2013-02-27 | |
| 2010-09-30 | $2.18M 10-Q · filed 2011-10-27 | $5.12M derived: sum of 2 quarters · filed 2011-10-27 | $7.87M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $2.94M 10-Q · filed 2011-07-29 | $5.69M 10-Q · filed 2011-07-29 | |||
| 2009-12-31 | $9.65M 10-K/A · filed 2012-03-19 |